Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infection, improving surveillance and diagnostic facilities, significant number of drugs in pipeline with better efficacy coupled with emerging vaccines with lower dosage and better effectiveness. Globally, the growth in Hepatitis B Treatment market is driven by backed by growing middle class population group demanding better drugs to improve lifestyle.
The global Hepatitis B Virus (HBV) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Among the type of treatment, therapeutics accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large population suffering with chronic Hepatitis B virus with unfulfilled need, improving access to healthcare, changing lifestyle and expanding middle class income group.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Virus (HBV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Virus (HBV).
Report Scope
The Hepatitis B Virus (HBV) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis B Virus (HBV) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B Virus (HBV) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Gilead Sciences
Novartis
GlaxoSmithKline
Hoffmann
La Roche
Bristol-Myers Squibb
Segment by Type
Therapeutics
Vaccine
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hepatitis B Virus (HBV) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis B Virus (HBV) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Therapeutics
1.2.3 Vaccine
1.3 Market by Application
1.3.1 Global Hepatitis B Virus (HBV) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis B Virus (HBV) Market Perspective (2019-2030)
2.2 Hepatitis B Virus (HBV) Growth Trends by Region
2.2.1 Global Hepatitis B Virus (HBV) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hepatitis B Virus (HBV) Historic Market Size by Region (2019-2024)
2.2.3 Hepatitis B Virus (HBV) Forecasted Market Size by Region (2025-2030)
2.3 Hepatitis B Virus (HBV) Market Dynamics
2.3.1 Hepatitis B Virus (HBV) Industry Trends
2.3.2 Hepatitis B Virus (HBV) Market Drivers
2.3.3 Hepatitis B Virus (HBV) Market Challenges
2.3.4 Hepatitis B Virus (HBV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis B Virus (HBV) Players by Revenue
3.1.1 Global Top Hepatitis B Virus (HBV) Players by Revenue (2019-2024)
3.1.2 Global Hepatitis B Virus (HBV) Revenue Market Share by Players (2019-2024)
3.2 Global Hepatitis B Virus (HBV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hepatitis B Virus (HBV) Revenue
3.4 Global Hepatitis B Virus (HBV) Market Concentration Ratio
3.4.1 Global Hepatitis B Virus (HBV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B Virus (HBV) Revenue in 2023
3.5 Hepatitis B Virus (HBV) Key Players Head office and Area Served
3.6 Key Players Hepatitis B Virus (HBV) Product Solution and Service
3.7 Date of Enter into Hepatitis B Virus (HBV) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis B Virus (HBV) Breakdown Data by Type
4.1 Global Hepatitis B Virus (HBV) Historic Market Size by Type (2019-2024)
4.2 Global Hepatitis B Virus (HBV) Forecasted Market Size by Type (2025-2030)
5 Hepatitis B Virus (HBV) Breakdown Data by Application
5.1 Global Hepatitis B Virus (HBV) Historic Market Size by Application (2019-2024)
5.2 Global Hepatitis B Virus (HBV) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hepatitis B Virus (HBV) Market Size (2019-2030)
6.2 North America Hepatitis B Virus (HBV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hepatitis B Virus (HBV) Market Size by Country (2019-2024)
6.4 North America Hepatitis B Virus (HBV) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hepatitis B Virus (HBV) Market Size (2019-2030)
7.2 Europe Hepatitis B Virus (HBV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hepatitis B Virus (HBV) Market Size by Country (2019-2024)
7.4 Europe Hepatitis B Virus (HBV) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis B Virus (HBV) Market Size (2019-2030)
8.2 Asia-Pacific Hepatitis B Virus (HBV) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hepatitis B Virus (HBV) Market Size by Region (2019-2024)
8.4 Asia-Pacific Hepatitis B Virus (HBV) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hepatitis B Virus (HBV) Market Size (2019-2030)
9.2 Latin America Hepatitis B Virus (HBV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hepatitis B Virus (HBV) Market Size by Country (2019-2024)
9.4 Latin America Hepatitis B Virus (HBV) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis B Virus (HBV) Market Size (2019-2030)
10.2 Middle East & Africa Hepatitis B Virus (HBV) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hepatitis B Virus (HBV) Market Size by Country (2019-2024)
10.4 Middle East & Africa Hepatitis B Virus (HBV) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Hepatitis B Virus (HBV) Introduction
11.1.4 Merck Revenue in Hepatitis B Virus (HBV) Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Hepatitis B Virus (HBV) Introduction
11.2.4 Gilead Sciences Revenue in Hepatitis B Virus (HBV) Business (2019-2024)
11.2.5 Gilead Sciences Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Hepatitis B Virus (HBV) Introduction
11.3.4 Novartis Revenue in Hepatitis B Virus (HBV) Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Hepatitis B Virus (HBV) Introduction
11.4.4 GlaxoSmithKline Revenue in Hepatitis B Virus (HBV) Business (2019-2024)
11.4.5 GlaxoSmithKline Recent Development
11.5 Hoffmann
11.5.1 Hoffmann Company Detail
11.5.2 Hoffmann Business Overview
11.5.3 Hoffmann Hepatitis B Virus (HBV) Introduction
11.5.4 Hoffmann Revenue in Hepatitis B Virus (HBV) Business (2019-2024)
11.5.5 Hoffmann Recent Development
11.6 La Roche
11.6.1 La Roche Company Detail
11.6.2 La Roche Business Overview
11.6.3 La Roche Hepatitis B Virus (HBV) Introduction
11.6.4 La Roche Revenue in Hepatitis B Virus (HBV) Business (2019-2024)
11.6.5 La Roche Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Hepatitis B Virus (HBV) Introduction
11.7.4 Bristol-Myers Squibb Revenue in Hepatitis B Virus (HBV) Business (2019-2024)
11.7.5 Bristol-Myers Squibb Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Merck
Gilead Sciences
Novartis
GlaxoSmithKline
Hoffmann
La Roche
Bristol-Myers Squibb
*If Applicable.